Showing results (2191-2200 of 2,898) with videos related to
Sort By:
Pageof 290
European Journal of Investigation in Health, Psychology and Education|April 26, 2024
Assessing We-Disease Appraisals of Health Problems: Development and Validation of the We-Disease QuestionnaireAlexandra J Vogt, Lasse Bartels, Isabella C Bertschi, et al.Journal of Pharmaceutical Sciences|April 6, 2016
Mouse Models for Assessing Protein Immunogenicity: Lessons and ChallengesWim Jiskoot, Grzegorz Kijanka, Theodore W Randolph, et al.PDA Journal of Pharmaceutical Science and Technology|April 20, 2016
A Biopharmaceutical Industry Perspective on the Control of Visible Particles in Biotechnology-Derived Injectable Drug ProductsSerge Mathonet, Hanns-Christian Mahler, Stefan T Esswein, et al.Antioxidants (Basel, Switzerland)|April 23, 2022
NRF2 Alters Mitochondrial Gene Expression in Neonate Mice Exposed to HyperoxiaHeather L Vellers, Hye-Youn Cho, Wesley Gladwell, et al.Rheumatology Advances in Practice|July 31, 2023
Day-to-day fluctuations of fatigue severity in individuals with knee osteoarthritis: an ecological momentary assessment approachMichelle W J Heijman, Cornelia H M van den Ende, Yvonne A S Peters, et al.Allergy|February 17, 2012
Symptom profile and risk factors of anaphylaxis in Central EuropeM Worm, G Edenharter, F Ruëff, et al.Respiratory Care|May 3, 2018
Results of a Pulmonologist Survey Regarding Knowledge and Practices With Inhalation Devices for COPDSidney S Braman, Brian W Carlin, Nicola A Hanania, et al.The European Respiratory Journal|February 28, 2002
A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseR Casaburi, D A Mahler, P W Jones, et al.American Journal of Respiratory and Critical Care Medicine|May 14, 2010
Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropiumJames F Donohue, Charles Fogarty, Jan Lötvall, et al.Critical Pathways in Cardiology|May 18, 2013
Avoidable utilization of the chest pain observation unit: evaluation of very-low-risk patientsSimon A Mahler, Gregory L Burke, David C Goff, et al.Pageof 290